A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

OU Health has become the first health system in Oklahoma to use Cytalux, a groundbreaking technology that helps detect cancer cells during surgery.

Other causes of lung cancer are well known, like radon gas exposure, which happens to be fairly prevalent in Appalachia. It’s ...

During a Case-Based Roundtable® event, Patrick M. Forde, MD, discussed safety and tolerability concerns with immunotherapy in ...

OU Health marked a significant breakthrough for Oklahoma in lung cancer treatment, becoming the first health care system in ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Lung cancer treatment has advanced, but it remains a leading cause of death due to late detection, treatment resistance, and ...

Smoking leads to cancer. That's known. But what new research shows is quitting smoking soon after a diagnosis helps patients ...

Treatment for oncogene-driven lung cancer often begins with targeted therapy, which tends to offer benefits over chemotherapy ...

Jemperli plus chemotherapy demonstrated superior overall survival compared to Keytruda in advanced NSCLC, with a median OS of ...

Thanks to advances in medicine, an Arkansas man was able to get diagnosed and overcome stage 4 lung cancer. Now, he's sharing ...